Plain-English translation of NCT07243379 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing , a medication designed to help cancer patients who are experiencing cachexia — a serious condition where the body loses weight and muscle mass due to cancer. Researchers want to understand how well this medication works and how safe it is when used in real-world conditions alongside standard cancer treatments. The study will follow nearly 500 patients to gather information about whether this treatment helps patients maintain their weight and strength.
Cancer cachexia is a devastating side effect that weakens patients and can make it harder to tolerate cancer treatment. While this medication exists, doctors need real-world evidence showing how effective and safe it truly is when patients use it in everyday clinical practice, not just in controlled research settings.
You likely qualify if…
You likely don't qualify if…
You would take the oral medication regularly as part of your cancer treatment plan. The study is observational, meaning researchers will monitor and document how you respond to the treatment — your weight, appetite, strength, and any side effects — over time. You will likely have regular follow-up visits where doctors check on your progress and collect information about how the medication is working for you.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
China